September 22, 2022
Article
The Vaccines and Related Biological Products Advisory Committee's (VRBPAC) positive vote follows the committee’s review of the data from the biologics license application (BLA) for RBX2660.
September 21, 2022
Video
Dr Teena Chopra shares her approach to monitoring patients with C difficile infection (CDI).
Drs Tom Lodise and Bincy Abraham provide an overview of fecal microbiota transplantation and long-term safety of FMT use.
September 20, 2022
Bifidobacterium and Bacteroides in the gut microbiome are important to vaccine responsiveness and could be used in vaccine adjuvants in the future, a recent review shows.
September 16, 2022
Compared to fidaxomicin and vancomycinfecal, microbiota transplant (FMT) was the most cost-effective treatment for first and subsequent recurrent C difficile infection.
September 14, 2022
Experts review treatment options for first, second and recurring episodes of Clostridioides difficile infection.
A gastroenterologist reviews long-term impact of dysbiosis and C. difficile infection (CDI).
September 07, 2022
Dr. Tom Lodise provides an overview of gut microbiota and the consequences of dysbiosis.
Dr. Abraham discusses importance of differential diagnosis of C. difficile infection (CDI) in patients with IBD and how both IBD and CDI should be managed.
August 31, 2022
A gastroenterologist, Dr. Bincy Abraham, provides an overview of C. difficile infection (CDI) in patients with inflammatory bowel disease (IBD).
Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe
Antibiotic Stewardship in Outpatient Care
Rapid, Reliable Diagnostic and PoC Tests Are Requisite for “Test to Treat"
HCV Not Associated With Myocarditis Risks for Young HIV Patients
